429 related articles for article (PubMed ID: 19636100)
1. An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres.
Stevanović M; Maksin T; Petković J; Filipic M; Uskoković D
Nanotechnology; 2009 Aug; 20(33):335102. PubMed ID: 19636100
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional PLGA particles containing poly(l-glutamic acid)-capped silver nanoparticles and ascorbic acid with simultaneous antioxidative and prolonged antimicrobial activity.
Stevanović M; Bračko I; Milenković M; Filipović N; Nunić J; Filipič M; Uskoković DP
Acta Biomater; 2014 Jan; 10(1):151-62. PubMed ID: 23988864
[TBL] [Abstract][Full Text] [Related]
3. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
4. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the permeability of hair growing ingredient encapsulated PLGA nanospheres to hair follicles and their hair growing effects.
Tsujimoto H; Hara K; Tsukada Y; Huang CC; Kawashima Y; Arakaki M; Okayasu H; Mimura H; Miwa N
Bioorg Med Chem Lett; 2007 Sep; 17(17):4771-7. PubMed ID: 17658251
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
7. Morphological changes of poly(DI-lactide-co-glycolide) nano-particles containing ascorbic acid during in vitro degradation process.
Stevanović M; Jordović B; Uskoković D
J Microsc; 2008 Dec; 232(3):511-6. PubMed ID: 19094031
[TBL] [Abstract][Full Text] [Related]
8. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
10. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
[TBL] [Abstract][Full Text] [Related]
11. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes.
Cheng FY; Wang SP; Su CH; Tsai TL; Wu PC; Shieh DB; Chen JH; Hsieh PC; Yeh CS
Biomaterials; 2008 May; 29(13):2104-12. PubMed ID: 18276001
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated biodegradation of poly(DL-lactide-co-glycolide) in vitro.
Xia Z; Huang Y; Adamopoulos IE; Walpole A; Triffitt JT; Cui Z
J Biomed Mater Res A; 2006 Dec; 79(3):582-90. PubMed ID: 16817218
[TBL] [Abstract][Full Text] [Related]
13. Histological examination of PLGA nanospheres for intratracheal drug administration.
Hara K; Tsujimoto H; Tsukada Y; Huang CC; Kawashima Y; Tsutsumi M
Int J Pharm; 2008 May; 356(1-2):267-73. PubMed ID: 18276091
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
Cenni E; Granchi D; Avnet S; Fotia C; Salerno M; Micieli D; Sarpietro MG; Pignatello R; Castelli F; Baldini N
Biomaterials; 2008 Apr; 29(10):1400-11. PubMed ID: 18191195
[TBL] [Abstract][Full Text] [Related]
15. Fabrication, in vitro degradation and the release behaviours of poly(DL-lactide-co-glycolide) nanospheres containing ascorbic acid.
Stevanović M; Savić J; Jordović B; Uskoković D
Colloids Surf B Biointerfaces; 2007 Oct; 59(2):215-23. PubMed ID: 17596919
[TBL] [Abstract][Full Text] [Related]
16. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
18. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
[TBL] [Abstract][Full Text] [Related]
19. Poly (lactide-co-glycolide) acid nanoencapsulation of a synthetic coumarin: cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target.
Bhattacharyya SS; Paul S; De A; Das D; Samadder A; Boujedaini N; Khuda-Bukhsh AR
Toxicol Appl Pharmacol; 2011 Jun; 253(3):270-81. PubMed ID: 21549736
[TBL] [Abstract][Full Text] [Related]
20. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM
J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
